|
Name |
Diaporthichalasin B
|
| Molecular Formula | C28H37NO4 | |
| IUPAC Name* |
(1R,2R,3E,5S,7S,9E,11R,12S,14S,15R,16S)-2,12-dihydroxy-16-[(4-hydroxyphenyl)methyl]-5,7,14-trimethyl-13-methylidene-17-azatricyclo[9.7.0.01,15]octadeca-3,9-dien-18-one
|
|
| SMILES |
C[C@H]1C/C=C/[C@H]2[C@@H](C(=C)[C@H]([C@@H]3[C@@]2([C@@H](/C=C/[C@H](C1)C)O)C(=O)N[C@H]3CC4=CC=C(C=C4)O)C)O
|
|
| InChI |
InChI=1S/C28H37NO4/c1-16-6-5-7-22-26(32)19(4)18(3)25-23(15-20-9-11-21(30)12-10-20)29-27(33)28(22,25)24(31)13-8-17(2)14-16/h5,7-13,16-18,22-26,30-32H,4,6,14-15H2,1-3H3,(H,29,33)/b7-5+,13-8+/t16-,17+,18+,22-,23-,24+,25-,26+,28+/m0/s1
|
|
| InChIKey |
UPGOOTAUZGTPNB-WZHGOZAJSA-N
|
|
| Synonyms |
Diaporthichalasin B; CHEMBL4451163
|
|
| CAS | NA | |
| PubChem CID | 146683413 | |
| ChEMBL ID | CHEMBL4451163 |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 451.6 | ALogp: | 3.9 |
| HBD: | 4 | HBA: | 4 |
| Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 89.8 | Aromatic Rings: | 4 |
| Heavy Atoms: | 33 | QED Weighted: | 0.501 |
| Caco-2 Permeability: | -5.36 | MDCK Permeability: | 0.00000750 |
| Pgp-inhibitor: | 0 | Pgp-substrate: | 0.991 |
| Human Intestinal Absorption (HIA): | 0.392 | 20% Bioavailability (F20%): | 0.765 |
| 30% Bioavailability (F30%): | 0.188 |
| Blood-Brain-Barrier Penetration (BBB): | 0.085 | Plasma Protein Binding (PPB): | 80.79% |
| Volume Distribution (VD): | 0.59 | Fu: | 3.32% |
| CYP1A2-inhibitor: | 0.078 | CYP1A2-substrate: | 0.134 |
| CYP2C19-inhibitor: | 0.592 | CYP2C19-substrate: | 0.633 |
| CYP2C9-inhibitor: | 0.7 | CYP2C9-substrate: | 0.92 |
| CYP2D6-inhibitor: | 0.069 | CYP2D6-substrate: | 0.78 |
| CYP3A4-inhibitor: | 0.878 | CYP3A4-substrate: | 0.203 |
| Clearance (CL): | 5.201 | Half-life (T1/2): | 0.36 |
| hERG Blockers: | 0.245 | Human Hepatotoxicity (H-HT): | 0.782 |
| Drug-inuced Liver Injury (DILI): | 0.633 | AMES Toxicity: | 0.044 |
| Rat Oral Acute Toxicity: | 0.946 | Maximum Recommended Daily Dose: | 0.993 |
| Skin Sensitization: | 0.478 | Carcinogencity: | 0.023 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.011 |
| Respiratory Toxicity: | 0.968 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC004118 | ![]() |
0.838 | D0S2BV | ![]() |
0.267 | ||
| ENC006133 | ![]() |
0.800 | D00LFB | ![]() |
0.240 | ||
| ENC003718 | ![]() |
0.784 | D0I0DL | ![]() |
0.231 | ||
| ENC004371 | ![]() |
0.743 | D04XEG | ![]() |
0.226 | ||
| ENC004120 | ![]() |
0.694 | D0J7RK | ![]() |
0.224 | ||
| ENC004372 | ![]() |
0.675 | D0B3QM | ![]() |
0.219 | ||
| ENC004369 | ![]() |
0.655 | D06ALD | ![]() |
0.218 | ||
| ENC004370 | ![]() |
0.640 | D01TNW | ![]() |
0.216 | ||
| ENC004243 | ![]() |
0.640 | D0Y2NE | ![]() |
0.215 | ||
| ENC003955 | ![]() |
0.622 | D01CRB | ![]() |
0.212 | ||